The Clorox Company (NYSE:CLX) Shares Acquired by Koshinski Asset Management Inc.

Koshinski Asset Management Inc. raised its stake in shares of The Clorox Company (NYSE:CLX) by 17.0% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,166 shares of the company’s stock after purchasing an additional 606 shares during the quarter. Koshinski Asset Management Inc.’s holdings in Clorox were worth $690,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in CLX. Bogart Wealth LLC increased its stake in shares of Clorox by 73.1% in the second quarter. Bogart Wealth LLC now owns 180 shares of the company’s stock worth $32,000 after acquiring an additional 76 shares during the period. Corsicana & Co. purchased a new stake in Clorox during the second quarter worth $49,000. Deseret Mutual Benefit Administrators purchased a new stake in Clorox during the second quarter worth $61,000. Eubel Brady & Suttman Asset Management Inc. purchased a new stake in Clorox during the second quarter worth $65,000. Finally, Marshall Wace North America L.P. purchased a new stake in Clorox during the first quarter worth $65,000. Hedge funds and other institutional investors own 76.61% of the company’s stock.

Clorox stock opened at $168.07 on Thursday. The company has a debt-to-equity ratio of 3.45, a current ratio of 0.69 and a quick ratio of 0.39. The Clorox Company has a 1-year low of $156.23 and a 1-year high of $231.11. The company has a market cap of $20.65 billion, a PE ratio of 48.58, a price-to-earnings-growth ratio of 4.37 and a beta of 0.18. The stock’s 50 day moving average price is $164.25 and its 200 day moving average price is $171.52.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Sunday, October 31st. The company reported $1.21 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.03 by $0.18. Clorox had a return on equity of 84.70% and a net margin of 6.04%. The firm had revenue of $1.81 billion for the quarter, compared to the consensus estimate of $1.70 billion. During the same period in the previous year, the business earned $3.22 earnings per share. The company’s revenue for the quarter was down 5.7% compared to the same quarter last year. On average, equities research analysts anticipate that The Clorox Company will post 5.46 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 11th. Investors of record on Wednesday, January 26th will be paid a $1.16 dividend. The ex-dividend date is Tuesday, January 25th. This represents a $4.64 dividend on an annualized basis and a dividend yield of 2.76%. Clorox’s dividend payout ratio (DPR) is presently 134.10%.

Several equities analysts have issued reports on CLX shares. Zacks Investment Research downgraded shares of Clorox from a “hold” rating to a “strong sell” rating and set a $139.00 price objective on the stock. in a report on Friday, August 6th. Deutsche Bank Aktiengesellschaft raised their price target on shares of Clorox from $156.00 to $160.00 and gave the stock a “hold” rating in a research note on Tuesday, November 2nd. Credit Suisse Group decreased their price target on shares of Clorox from $175.00 to $160.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 4th. Atlantic Securities cut shares of Clorox from an “overweight” rating to a “neutral” rating and set a $150.00 price objective for the company. in a research report on Wednesday, August 4th. Finally, Morgan Stanley cut their price objective on shares of Clorox from $160.00 to $154.00 and set an “underweight” rating for the company in a research report on Wednesday, October 13th. Six analysts have rated the stock with a sell rating, nine have assigned a hold rating and three have issued a buy rating to the company’s stock. According to data from, the company presently has a consensus rating of “Hold” and an average price target of $179.22.

In other Clorox news, SVP Diego J. Barral sold 240 shares of the business’s stock in a transaction on Tuesday, November 16th. The stock was sold at an average price of $170.00, for a total transaction of $40,800.00. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 0.58% of the stock is currently owned by insiders.

Clorox Profile

The Clorox Co engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Cleaning, Lifestyle, Household, and International. The Cleaning segment consists of laundry, home care, and professional products marketed and sold in the United States.

See Also: FinTech

Want to see what other hedge funds are holding CLX? Visit to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with's FREE daily email newsletter.